Saturday, July 11, 2026

Drug profile · INN

cefpiramide sodium

cefpiramide sodium (CEFPIRAMIDE SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — cefpiramide sodium
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

cefpiramide sodium (CEFPIRAMIDE SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN cefpiramide sodium
Brand CEFPIRAMIDE SODIUM
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Bacterial penicillin-binding protein inhibitor

Primary target: Bacterial penicillin-binding protein

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amoxicillin Bacterial penicillin-binding protein inhibitor
  2. ampicillin sodium Bacterial penicillin-binding protein inhibitor
  3. ampicillin/ampicillin trihydrate Bacterial penicillin-binding protein inhibitor
  4. cefaclor Bacterial penicillin-binding protein inhibitor
  5. cefadroxil/cefadroxil hemihydrate Bacterial penicillin-binding protein inhibitor
  6. cefazolin sodium Bacterial penicillin-binding protein inhibitor

Frequently asked questions

What is cefpiramide sodium?

cefpiramide sodium (CEFPIRAMIDE SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for cefpiramide sodium?

CEFPIRAMIDE SODIUM is a marketed brand name for cefpiramide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cefpiramide sodium?

cefpiramide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.